Case Report
Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case Report
Figure 3
Image of left frontal lobe lesion from CT scan at diagnosis (a) and reevaluation CT scan performed six weeks after the initiation of osimertinib (b), showing a partial response (from 18 mm to 8 mm).
| (a) |
| (b) |